UNSPSC 51201654: COVID19 - Moderna

A mRNA vaccine composed of nucleoside-modified mRNA (modRNA) encoding a spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles.

UNSPSC 51201654 COVID19 - Moderna is a Commodity code that covers pharmaceutical vaccines and immunizing agents procured by state and local health departments. Recent activity shows that state health agencies are acquiring vaccines through sole source procurement mechanisms when they determine a single vendor is the exclusive supplier. The Mississippi State Department of Health posted a sole source notice for Yellow Fever Vaccine from Sanofi Pasteur in July 2026, demonstrating that state health departments use this code to procure vaccines where competitive alternatives do not exist or where regulatory or clinical requirements limit sourcing. The procurement framework allows objectors to challenge sole source designations by demonstrating the availability of competing suppliers, after which the issuing agency must either conduct a competitive solicitation or defend the sole source determination before the state procurement review board.

The source contains only one recent opportunity under this code. The Mississippi State Department of Health's July 2026 sole source notice for Yellow Fever Vaccine (due August 3, 2026) represents the extent of documented recent state and local activity. The notice did not specify contract value, quantity, or term. No other states or jurisdictions appear in the recent-opportunities block. Given the sparse activity and the mismatch between the code's nominal name (COVID19 - Moderna) and the actual procurement (Yellow Fever Vaccine from Sanofi Pasteur), this code shows little relevant recent activity for state and local procurement professionals evaluating current market demand.